Old Web
English
Sign In
Acemap
>
Paper
>
408OSitravatinib demonstrates activity in patients with novel genetic alterations that inactivate CBL
408OSitravatinib demonstrates activity in patients with novel genetic alterations that inactivate CBL
2018
Lyudmila Bazhenova
Richard D. Carvajal
B.C. Cho
K Eaton
Sanjay Goel
Rebecca S. Heist
M Ingham
D. Wang
Theresa L. Werner
Saskia Neuteboom
Diane Potvin
Isan Chen
James G. Christensen
R. Chao
Ajjai Alva
Keywords:
Pathology
Medicine
Cancer research
Sitravatinib
Bioinformatics
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]